
Kennedy's new vaccine advisers meet for first time
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
It's one signal that this week's two-day meeting of the Advisory Committee on Immunization Practices isn't business as usual.
Advertisement
Another sign: Shortly before the meeting, a Virginia-based obstetrician and gynecologist stepped down from the committee, bringing the panel's number to just seven. The Trump administration said Dr. Michael Ross withdrew during a customary review of members' financial holdings.
The meeting opened as the American Academy of Pediatrics announced that it will continue publishing its own vaccine schedule for children but now will do so independently of the ACIP, calling it 'no longer a credible process.'
The panel, created more than 60 years ago, helps the CDC determine who should be vaccinated against a long list of diseases, and when. Those recommendations have a big impact on whether insurance covers vaccinations and where they're available, such as at pharmacies.
Advertisement
Earlier this month, Kennedy
The highly unusual moves prompted a last-minute plea from a prominent Republican senator to delay this week's meeting. Sen. Bill Cassidy of Louisiana, a physician who chairs the chamber's health committee, said Monday that many of Kennedy's chosen panelists lack the required expertise and 'may even have a preconceived bias' against new vaccine technologies.
In a House hearing Tuesday, Kennedy defended his purge, saying the old panel had been 'a template for medical malpractice.'
Rep. Kim Schrier, a pediatrician and Democrat from Washington state, told Kennedy: 'I will lay all responsibility for every death from a vaccine-preventable illness at your feet.'
Committee will vote on RSV protections
The two-day meeting's agenda on was abruptly
Discussion of COVID-19 shots will open the session on Wednesday. Later in the day, the committee will take up RSV, with votes expected. On Thursday, the committee will vote on fall flu vaccinations and on the use of a preservative in certain flu shots.
In 2023, U.S. health officials began
Advertisement
The committee will discuss another company's newly approved antibody shot, but the exact language for the vote was not released prior to the meeting.
'I think there may be a theme of soft-pedaling or withdrawing recommendations for healthy pregnant women and healthy children,' even though they are at risk from vaccine-preventable diseases, said Lawrence Gostin, a public health law expert at Georgetown University who co-authored a recent
Flu shot recommendations to be debated
At its June meetings, the committee usually refreshes guidance for Americans 6 month and older to get a flu shot, and helps greenlight the annual fall vaccination campaign.
But given the recent changes to the committee and federal public health leadership, it's unclear how routine topics will be treated, said Jason Schwartz, a Yale University health policy researcher who has studied the committee.
Thursday also promises controversy. The advisory panel is set to consider a preservative in a subset of flu shots that Kennedy and some antivaccine groups have falsely contended is tied to autism. In preparation, the CDC posted a new report confirming that research shows no link between the preservative, thimerosal, and autism or any other neurodevelopmental disorders.
Gostin said the agenda appears to be 'a combination of what we would normally expect ACIP to cover along with a mixture of potential conspiracy theories,' he said. 'We clearly are in a new normal that's highly skeptical of vaccine science.'
The committee's recommendations traditionally go to the Centers for Disease Control and Prevention director. Historically, nearly all are accepted and then used by insurance companies in deciding what vaccines to cover.
Advertisement
But the CDC currently has no director, so the committee's recommendations have been going to Kennedy, and he has yet to act on a couple recommendations ACIP made in April.
The
___
Neergaard reported from Washington.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Claritev Corporation Joins Coalition for Health AI to Advance Responsible AI in Healthcare
Claritev Corporation (NYSE:CTEV) is one of the best-performing NYSE stocks to buy now. On June 17, Claritev Corporation announced its membership in the Coalition for Health AI/CHAI. CHAI is an industry-led coalition dedicated to establishing best practices and frameworks for innovation, safety, and security in health AI. Claritev aims to enhance healthcare affordability, transparency, and fairness. The collaboration will help develop and deploy responsible AI practices within the healthcare ecosystem. Claritev intends to contribute its expertise in healthcare data integration and analytics to CHAI's initiatives, particularly in areas such as transparency, fairness, safety, and privacy in AI. A healthcare professional using a digital device to provide a health risk assessment to a patient. Claritev provides solutions and services powered by over 40 years of claims processing data, using technology and AI to offer insights that drive affordability and price transparency. Claritev serves 700+ healthcare payors, 100,000+ employers, 60 million consumers, and 1.4 million contracted providers. The coalition comprises leaders and experts from health systems, startups, government, and patient advocacy groups. Claritev Corporation (NYSE:CTEV) provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the US. While we acknowledge the potential of CTEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.


Los Angeles Times
20 minutes ago
- Los Angeles Times
U.S. strikes crippled Iran's nuclear program, Israeli analysis finds
THE HAGUE — Israel's preliminary analysis of the damage caused by U.S. strikes on Iran's main nuclear facilities — based in part from on-the-ground assessments — shows the attacks inflicted widespread destruction, a senior Israeli official said. The official, granted anonymity to speak candidly, said that Tehran has been 'actively trying to hide the damage' from the attacks, which President Trump said in The Hague on Wednesday had all but eliminated Iran's enrichment program. Trump, who repeatedly defended the effectiveness of the strikes at the NATO Summit, made reference to individuals who had been on the ground to assess the damage, without providing details. 'I can't say it's a final assessment, because we're less than a week after. It's not like we can send officers openly. But that's the indication we have now,' the official said. A spokesperson for Iran's foreign ministry on Wednesday said the bombing raid 'badly damaged' the nuclear sites, but the Iranian government has said it will continue its nuclear efforts, which it insists are for peaceful purposes. A full review of the mission could take weeks, and experts have expressed skepticism of declarative statements by Trump and Defense Secretary Pete Hegseth that the U.S. operation was a success within mere days of the attack. 'Battlefield damage assessment is an imprecise art, with initial estimates frequently being way off,' said Patrick Clawson, an expert on Iran and director for research at The Washington Institute for Near East Policy. 'I would be very suspicious of any claims — by Iran, by Trump, by Israel — about what has happened to Iran's enriched uranium stocks or to its centrifuges.' Israel's preliminary findings come after an initial assessment from the U.S. Defense Intelligence Agency cast doubt on the effectiveness of the American strikes, stating with low confidence that Iran had retained the core elements of its nuclear program despite the attacks, one U.S. official familiar with the findings told The Times. The DIA assessment was first reported by CNN. The U.S. attack followed nine days of an Israeli military campaign that decimated Iran's air defenses, its military leadership and its ballistic missile stockpiles, while degrading its nuclear facilities. Israeli intelligence has also monitored the reaction to the campaign among Iranian leadership, which has struggled to comprehend the extent of the damage itself, the Israeli official said. 'We don't believe everyone in the leadership knows what really happened, because the whole program was compartmentalized — they weren't sharing a lot of information, and a lot of the officers who were highly involved on the ground level were eliminated,' the official continued. 'So a lot of the top leadership hasn't fully begun to understand what's happened.' The developing intelligence picture comes as Trump defended the U.S. mission, called Operation Midnight Hammer, during multiple appearances at the NATO Summit in The Hague on Wednesday. 'It's been obliterated, totally obliterated,' he said of Iran's nuclear facilities. Addressing the DIA report, he added, 'They did a report, but it was like, if you look at the dates, it's just a few days after.' The U.S. deployment of massive, 'bunker-buster' munitions targeting Iran's main nuclear sites — including six dropped on Fordo, a facility burrowed deep into the side of a mountain — was intended to bury its most advanced equipment and most highly enriched uranium, which can be used to build nuclear warheads. Initial assessments of the damage were unclear, but since then, Trump said, 'we've collected additional intelligence. We've also spoken to people that have seen the site, and the site is obliterated.'

Wall Street Journal
21 minutes ago
- Wall Street Journal
How ‘Daddy' Trump Learned to Love NATO
THE HAGUE—What a difference one night in a Dutch palace can make. President Trump departed Washington early Tuesday in a bad mood, swearing at Israel and Iran for endangering the cease-fire he had brokered and sweating from a heat wave blanketing the capital.